National Institutes of Health closed grants
1,215 federal funding opportunities from National Institutes of Health (HHS-NIH11) that have closed, as they were listed on Grants.gov, newest close first (401–500 of 1,215, page 5 of 13).
HHS-NIH11 overviewPage 1Page 2Page 3Page 4Page 6Page 7Page 8Page 9Page 10Page 11Page 12Page 13
- Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders (DP1- Clinical Trial Not Allowed)
- Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed)
- Centers for AIDS Research (P30 Clinical Trial Not Allowed)
- Functional Validation and/or Characterization of Genes or Variants Implicated in Substance Use Disorders (R21/R33 Clinical Trial Not Allowed)
- NIDDK Catalyst Award (DP1 Clinical Trial Not Allowed)
- Instrumentation Grant Program for Resource-Limited Institutions (S10 - Clinical Trial Not Allowed)
- NIDDK Central Repository Non-renewable Sample Access (X01 Clinical Trial Not Allowed)
- Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional)
- Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3 Clinical Trial Optional)
- The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed)
- Asthma and Allergic Diseases Cooperative Research Centers (U19 Clinical Trial Optional)
- Discovery and Development of Natural Products for Cancer Interception and Prevention (UG3/UH3 Clinical Trial Not Allowed)
- Molecular Mechanisms of Combination Adjuvants (MMCA) (R01 Clinical Trial Not Allowed)
- NIDDK Centers for Diabetes Translation Research (P30 Clinical Trial Optional)
- Nutrition Obesity Research Centers (P30 Clinical Trial Optional)
- HEAL Initiative: Interdisciplinary Team Science to Uncover the Mechanisms of Pain Relief by Medical Devices (RM1 Clinical Trial Optional)
- Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P50 Clinical Trial Optional)
- High-Priority Research in Tobacco Regulatory Science (R01 Clinical Trial Optional)
- CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Translational Exploratory/Developmental Research Projects (R21 Clinical Trial Not Allowed)
- Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional)
- ClinGen Genomic Curation Expert Panels (U24 Clinical Trial Not Allowed)
- NIMH Research Education Programs for Psychiatry Residents (R25- Independent Clinical Trial Not Allowed)
- NIMH Mentoring Networks for Mental Health Research Education (R25 Clinical Trial Not Allowed)
- NIMH Short Courses for Mental Health Related Research (R25 -Independent Clinical Trial Not Allowed)
- Development of Resources and Technologies for Enhancing Rigor, Reproducibility, and Translatability of Animal Models in Biomedical Research (R24 Clinical Trials Not Allowed)
- Development of Animal Models and Related Biological Materials for Down Syndrome Research (R24 Clinical Trials Not-Allowed)
- NICHD Research Education Programs (R25 Clinical Trial Not Allowed)
- Building Sustainable Software Tools for Open Science (R03 Clinical Trial Not Allowed)
- Genetic Architecture of Mental Disorders in Ancestrally Varied Populations II (U01 Clinical Trial Not Allowed)
- Pilot Research Opportunities in Crisis Response Services for Suicide Prevention (R34 Clinical Trial Optional)
- Community Level Interventions to Improve Minority Health and Reduce Health Disparities (R01 - Clinical Trial Optional)
- CCRP Initiative: Chemical Threat Agent-induced Pulmonary and Ocular Pathophysiological Mechanisms (R01 Clinical Trial Not Allowed)
- BRAIN Initiative: Brain-Behavior Quantification and Synchronization Transformative and Integrative Models of Behavior at the Organismal Level (U01 Clinical Trials Not Allowed)
- BRAIN Initiative: Brain-Behavior Quantification and Synchronization Transformative and Integrative Models of Behavior at the Organismal Level (U01 Clinical Trial Optional)
- Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical Trial Required)
- Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed)
- Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)
- Elucidating Mechanisms Associated with HIV Related Co-Morbidities in Populations Experiencing Health Disparities (R01 - Clinical Trials Not Allowed)
- Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional)
- BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R21 Clinical Trial Optional)
- BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01 Clinical Trial Optional)
- NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)
- Understanding Mechanisms and Outcomes of Trained Immunity (R01 Clinical Trial Not Allowed)
- Understanding Mechanisms and Outcomes of Trained Immunity (R21 Clinical Trial Not Allowed)
- Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Human Required)
- Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)
- Native American Research Centers for Health (NARCH) Planning Grants (R34 - Clinical Trial Not Allowed)
- NIDCD Low Risk Clinical Trials in Communication Disorders (R01 Clinical Trial Required)
- Understanding the Impact of Healthcare System and Clinician Factors on Disparities in Maternal Morbidity and Mortality (R01 - Clinical Trial Optional)
- Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R61/R33 Basic Experimental Studies with Humans Required)
- Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R61/R33 Clinical Trial Optional)
- Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R01 Basic Experimental Studies with Humans Required)
- Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R01 Clinical Trial Optional)
- Interventions to Address HIV-Related Comorbidities among Highly Affected Populations Experiencing Health Disparities (R01 - Clinical Trial Required)
- HEAL Initiative: Research to Increase Implementation of Substance Use Preventive Services (R01 Clinical Trial Optional)
- HEAL Initiative: Research to Increase Implementation of Substance Use Preventive Services (R61/R33 Clinical Trial Optional)
- Opportunities for HIV Cure Strategies at the Time of ART Initiation (R01 Clinical Trial Not Allowed)
- Opportunities for HIV Cure Strategies at the Time of ART Initiation (R21 Clinical Trial Not Allowed)
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
- NIAID Clinical Trial Planning Grant (R34 Clinical Trial Not Allowed)
- HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional)
- Interventions for Stigma Reduction to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle- Income Countries (R01 - Clinical Trial Optional)
- Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed)
- STrengthening Research Opportunities for NIH Grants (STRONG): Structured Institutional Needs Assessment and Action Plan Development for Resource Limited Institutions (RLIs) (UC2 - Clinical Trial Not Allowed)
- International Research in Infectious Diseases (R01 Clinical Trial Not Allowed)
- Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Basic Experimental Studies with Humans (BESH) Required)
- Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)
- BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Basic Experimental Studies with Humans Required)
- Pulmonary Outcomes and Sequelae after Treatment-TB (POST-TB) (R01 Clinical Trial Optional)
- NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional)
- Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)
- Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R01 Clinical Trial Optional)
- Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R21 Clinical Trial Optional)
- Formative and Pilot Intervention Research to Optimize HIV Prevention and Care Continuum Outcomes (R34 Clinical Trial Optional)
- Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed)
- Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)
- NIMH Biobehavioral Research Awards for Innovative New Scientists (NIMH BRAINS) (R01 Clinical Trial Optional)
- Research to Action: Assessing and Addressing Community Exposures to Environmental Contaminants (R01 Clinical Trial Optional)
- Precision Approaches in Radiation Synthetic Combinations (PAIRS, R21 Clinical Trial Optional)
- Precision Approaches in Radiation Synthetic Combinations (PAIRS, R01 Clinical Trial Optional)
- Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes (R01 Clinical Trial Optional)
- IDeA Networks of Biomedical Research Excellence (INBRE) (P20 Clinical Trial Optional)
- Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed)
- Time-Sensitive Evaluation of Policies Affecting Health Behaviors and Chronic Disease Risk (R01-Clinical Trial Not Allowed)
- Maximizing Investigators' Research Award (R35 - Clinical Trial Optional)
- Diagnostic Centers of Excellence (X01 Clinical Trial Not Allowed)
- HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)
- Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional)
- Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional)
- Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R01 Clinical Trial Not Allowed)
- Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R01 Clinical Trial Not Allowed)
- Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R21 Clinical Trial Not Allowed)
- Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R21 Clinical Trial Not Allowed)
- Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 Clinical Trial Not Allowed)
- Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 Clinical Trial Not Allowed)
- Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional)
- NIDCR Dual Degree Dentist Scientist Predoctoral to Postdoctoral Transition Award (F99/K00 Independent Clinical Trial Not Allowed)
- Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32)
- Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)
- Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33)
Same-day alerts, matched to you
The free digest is weekly — the same list for everyone. Members get every open federal grant scored to their organization — and an alert the day a real match posts: we read every new posting the day it opens. Free for 30 days, then $29/mo. Card required, cancel any time before day 31. One free trial per customer.
Not ready for a subscription? A one-time Fit Report — $29 — scores every open federal grant to your organization once, by email within one business day.
Start 30 days free →Just want the free weekly list?
Get grants like this every Tuesday — free
One email a week: the biggest new federal grants and what’s closing soon — the same list for everyone. Unsubscribe any time.